Report by : Gan Yung Chyan
/ KUCINTA SETIA
Image courtesy : AFP
The Director General of the World Health Organization Tedros Adhanom Ghebreyesus said at an online press conference in Geneva on 17 June 2020 that the world must concentrate on accelerating the treatment of covid patients.
Tedros said that there was gratifying news from Britain on 16 June, and the test of dexamethasone had achieved positive preliminary results. This common steroid has been shown to have a beneficial effect on patients with severe diseases infected with SARS-CoV-2. He said that WHO will update clinical guidelines to reflect how and when dexamethasone should be used to treat patients with SARS-CoV-2.
On 17 June, the Head of WHO's Health Emergency Project Michael Ryan said that dexamethasone should be used under medical supervision, not for the prevention of covid. It should be only applied on critically ill patients with covid. On the same day, Restrepo, an official of the organization's immunization, vaccine and biological products department, said that he stopped the hydroxychloroquine branch test in the "Unity Test" project on the grounds that the drug failed to reduce the mortality rate of covid patients.
No comments:
Post a Comment